News & Perspective

Nov 04, 2011

Nov 04, 2011

CDC reports more novel H3N2 infections

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) today reported two more infections with swine-origin H3N2 influenza, including a case first announced by Maine 3 days ago and an additional illness in an Indiana patient.

The CDC also said flu activity in the United States is still at low levels, a pattern the World Health Organization (WHO) is also seeing in most parts of the world.

Oct 31, 2011

Oct 31, 2011

Manufacturers react cautiously to flu vaccine efficacy analysis

(CIDRAP News) – Companies that market influenza vaccines in the United States are reacting cautiously to last week's meta-analysis that highlighted gaps in the evidence for the efficacy of the vaccines, with officials stressing that vaccines are still the best preventive tool and that the firms are working to improve them.

Oct 25, 2011

Oct 25, 2011

Strict meta-analysis raises questions about flu vaccine efficacy

Editor’s Note: This article covers research conducted in part by CIDRAP researchers. Please note that CIDRAP News operates independently in relation to CIDRAP's research and policy programs.

See also: Public health groups say flu vaccine is best tool, despite limitations

Oct 21, 2011

Oct 21, 2011

WHO: Some tropical countries report flu activity

(CIDRAP News) – A few of the world's tropical countries are reporting active flu transmission, as the flu season continues in Australia and New Zealand, though activity is declining, the World Health Organization (WHO) reported today.

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Oct 13, 2011

Oct 13, 2011

Study comparing kids' flu vaccines suggests adjuvant benefits

(CIDRAP News) – A field trial in young children that compared an adjuvanted version of the seasonal flu vaccine with the conventional, non-adjuvanted version during two flu seasons found promising results for the boosted version, which might open up new options for a more effective vaccine strategy, researchers reported today.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»